Pharmaceutical Executive-07-01-2022

In DOJ Crosshairs: Rethinking Commission-Based Deals With Independent Contractors

July 08, 2022

Features

42

7

Pharma companies should review their commission-based compensation arrangements with independent contractors to address enforcement risk under the Anti-Kickback Statute, in light of recent Department of Justice enforcement.

A Steadying Force in C-Suite: The Changing Role of Biopharma CFOs

July 08, 2022

Features

42

7

COVID-19 pandemic, the challenging capital-markets climate in biotech, and a more innovative and specialty treatment focus has increased reliance on the finance arm as a key strategic cog.

Breaking Down Barriers

July 08, 2022

Executive Profile

42

7

Dealing with discrimination and bias throughout her career, Otsuka Pharmaceutical’s Christine Sakdalan has forged a strong leadership path built around a two-pronged mission—finding true meaning in the patient journey through market research and data analytics, and mentoring and supporting the development of today’s aspiring professionals.